Frontiers | Women in Drugs Outcomes Research and Policies: 2023

Women in Drugs Outcomes Research and Policies: 2023

4,176
Total downloads
15k
Total views and downloads

Articles

REVIEW

Published on 19 Aug 2024

The burden of systemic therapy administration route in treating HER2-positive breast cancer (for patients, healthcare professionals, and healthcare system): a systematic literature review

Luciana Castro Garcia Landeiro
Tamie de Camargo Martins
Ruth Bartelli Grigolon
Isabel Monteiro
Joana Bisol Balardin
Eduardo Padilha
Gilberto Amorim
Stephen Stefani

doi 10.3389/fphar.2024.1338546

949 views

BRIEF RESEARCH REPORT

Published on 12 Jul 2024

Is it time to recommend AUC-based vancomycin therapeutic drug monitoring only? A cross-sectional survey in China

Jieqiong Liu
Xuan Zhang
Gang Liang
Jianping Zhu
Yi Yang
Ying Zheng
Yun Han
Lingyan Yu
Yuhua Zhao
Zhenwei Yu

doi 10.3389/fphar.2024.1370040

772 views

ORIGINAL RESEARCH

Published on 19 Jun 2024

Implementation of risk-based lipid-lowering therapies in older (age ≥ 65 years) and very-old adults (age ≥ 75 years) with ischemic heart disease in the greater Salzburg region

Kristen Kopp
Lukas J. Motloch
Bernhard Wernly
Alexander E. Berezin
Victoria Maringgele
Anna Dieplinger
Uta C. Hoppe
Michael Lichtenauer

doi 10.3389/fphar.2024.1357334

722 views

ORIGINAL RESEARCH

Published on 17 Jun 2024

Treatment of hypertension during pregnancy: a cohort of pregnancy episodes from the SIDIAP database, Catalonia, Spain

Ainhoa Gomez-Lumbreras
Carles Vilaplana-Carnerero
Marta Lestón Vázquez
Cristina Vedia
Rosa Morros
Maria Giner-Soriano

doi 10.3389/fphar.2024.1346357

645 views

MINI REVIEW

Published on 22 May 2024

Improvements in technology and the expanding role of time-driven, activity-based costing to increase value in healthcare provider organizations: a literature review

Ana Paula Beck Da Silva Etges
Porter Jones
Harry Liu
Xiaoran Zhang
Derek Haas

doi 10.3389/fphar.2024.1345842

987 views

ORIGINAL RESEARCH

Published on 17 Apr 2024

Sotagliflozin versus dapagliflozin to improve outcome of patients with diabetes and worsening heart failure: a cost per outcome analysis

Weichen Zhang
Meichen Yu
Guohua Cheng

doi 10.3389/fphar.2024.1373314

2,159 views
2 citations

BRIEF RESEARCH REPORT

Published on 23 Feb 2024

Prevalence of inappropriateness of elemene injection for hospitalized cancer patients: a multicenter retrospective study

Mingzheng Cen
Guojun Jiang
Yuhua Zhao
Zhenwei Yu
Minxian Li

doi 10.3389/fphar.2024.1334701

447 views

ORIGINAL RESEARCH

Published on 29 Jan 2024

Real world drug treatment models for pregnancy complicated with urinary tract infection in China from 2018 to 2022: a cross-section analysis

Jing Jin
Changyan Li
Yuqing He
Jiaqian Pan
JiaLei Zhu
Jing Tang

doi 10.3389/fphar.2024.1349121

1,464 views
1 citation

ORIGINAL RESEARCH

Published on 24 Jan 2024

Clinical relevance and implementation into daily practice of pharmacist-prescribed medication for the management of minor ailments

Noelia Amador-Fernández
Irina Botnaru
Samuel Sebastian Allemann
Véronique Kälin
Jérôme Berger

doi 10.3389/fphar.2023.1256172

1,521 views

ORIGINAL RESEARCH

Published on 11 Jan 2024

Comparative price analysis of biological medicines: disparities generated by different pricing policies

Marcela Amaral Pontes
Alane Andrelino Ribeiro
Flávia Caixeta Albuquerque
Silvana Nair Leite Cotenzini

doi 10.3389/fphar.2023.1256542

1,839 views
2 citations

OPINION

Published on 24 Nov 2023

Leveraging stories of cardiac amyloidosis patients of African ancestry or descent to support patient-derived data elements for efficient diagnosis and treatment

Rachele M. Hendricks-Sturrup
Lauren M. Edgar
Christine Y. Lu

doi 10.3389/fphar.2023.1276396

811 views

Share on

Frontiers in Pharmacology

Drugs Outcomes Research and Policies

Impact

15kTopic views
10kArticle views
4,176Article downloads

View impact

Submit your idea

Articles

The burden of systemic therapy administration route in treating HER2-positive breast cancer (for patients, healthcare professionals, and healthcare system): a systematic literature review

Is it time to recommend AUC-based vancomycin therapeutic drug monitoring only? A cross-sectional survey in China

Implementation of risk-based lipid-lowering therapies in older (age ≥ 65 years) and very-old adults (age ≥ 75 years) with ischemic heart disease in the greater Salzburg region

Treatment of hypertension during pregnancy: a cohort of pregnancy episodes from the SIDIAP database, Catalonia, Spain

Improvements in technology and the expanding role of time-driven, activity-based costing to increase value in healthcare provider organizations: a literature review

Sotagliflozin versus dapagliflozin to improve outcome of patients with diabetes and worsening heart failure: a cost per outcome analysis

Prevalence of inappropriateness of elemene injection for hospitalized cancer patients: a multicenter retrospective study

Real world drug treatment models for pregnancy complicated with urinary tract infection in China from 2018 to 2022: a cross-section analysis

Clinical relevance and implementation into daily practice of pharmacist-prescribed medication for the management of minor ailments

Comparative price analysis of biological medicines: disparities generated by different pricing policies

Leveraging stories of cardiac amyloidosis patients of African ancestry or descent to support patient-derived data elements for efficient diagnosis and treatment

Frontiers in Pharmacology

Impact